News | December 28, 2021
CDSCO expert committee recommends Emergency Use Authorisation to Covovax and Corbevax
All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval.
All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval.
The approval of shelf life extension is based on the availability of additional stability data, which was submitted to the CDSCO
Jardiance is the first SGLT2-inhibitor therapy to prove reduction in risk of cardiovascular death in people with type-II diabetes and established cardiovascular disease
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO
The test combines sensitivity with speed and is designed to be used in health care settings to aid with rapid diagnosis of Covid-19
_256_384.jpg)
The two doses of Covaxin are likely to be administered to children with a gap of 28 days
This opens up a huge market for the company’s Magnezis implants in India
The approval will enable the treatment of patients in India living with Essential tremor, tremor-dominant Parkinson's Disease and neuropathic pain
It tests for the presence or absence of ribonucleic acid (RNA) of Dengue (Type 1, 2 4) in serum or plasma from patients suspected of dengue viral infection.
Subscribe To Our Newsletter & Stay Updated
